Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim L Jansen

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Current Opinion in Pulmonary Medicine|July 25, 2013
Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwideJohanna P Cremers, Marjolein Drent, Aalt Bast, et al.
Rheumatology (Oxford, England)|October 26, 2019
Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trialFemke B G Lamers-Karnebeek, Jolanda J Luime, Tim L Jansen, et al.
Nature Reviews. Rheumatology|August 20, 2014
Improving cardiovascular and renal outcomes in gout: what should we target?Pascal Richette, Fernando Perez-Ruiz, Michael Doherty, et al.
The European Respiratory Journal|February 22, 2014
Association of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosisPetal A Wijnen, Johanna P Cremers, Patty J Nelemans, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 7, 2010
[Practice guideline 'Diagnosis and treatment of rheumatoid arthritis']Lydia G Schipper, Monique Hoekstra, Thea P M Vliet Vlieland, et al.
Rheumatology (Oxford, England)|April 22, 2017
Performance of the 2015 ACR-EULAR classification criteria for gout in a primary care population presenting with monoarthritisHein J E M Janssens, Jaap Fransen, Matthijs Janssen, et al.
Rheumatology (Oxford, England)|November 2, 2018
Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activityFemke B G Lamers-Karnebeek, Johannes W G Jacobs, Timothy R D J Radstake, et al.
BJGP Open|February 20, 2020
Understanding the patient voice in gout: a quantitative study conducted in EuropeMarc De Meulemeester, Elsa Mateus, Hilda Wieberneit-Tolman, et al.
Annals of the Rheumatic Diseases|November 14, 2022
Clinical image: synovitis of the metacarpophalangeal jointsLinda van der Weele, Tom Niessink, Mario Maas, et al.
Annals of the Rheumatic Diseases|February 5, 2015
Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1RaTania O Crișan, Maartje C P Cleophas, Marije Oosting, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Current Opinion in Pulmonary Medicine|July 25, 2013
Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwideJohanna P Cremers, Marjolein Drent, Aalt Bast, et al.
Rheumatology (Oxford, England)|October 26, 2019
Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trialFemke B G Lamers-Karnebeek, Jolanda J Luime, Tim L Jansen, et al.
Nature Reviews. Rheumatology|August 20, 2014
Improving cardiovascular and renal outcomes in gout: what should we target?Pascal Richette, Fernando Perez-Ruiz, Michael Doherty, et al.
The European Respiratory Journal|February 22, 2014
Association of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosisPetal A Wijnen, Johanna P Cremers, Patty J Nelemans, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 7, 2010
[Practice guideline 'Diagnosis and treatment of rheumatoid arthritis']Lydia G Schipper, Monique Hoekstra, Thea P M Vliet Vlieland, et al.
Rheumatology (Oxford, England)|April 22, 2017
Performance of the 2015 ACR-EULAR classification criteria for gout in a primary care population presenting with monoarthritisHein J E M Janssens, Jaap Fransen, Matthijs Janssen, et al.
Rheumatology (Oxford, England)|November 2, 2018
Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activityFemke B G Lamers-Karnebeek, Johannes W G Jacobs, Timothy R D J Radstake, et al.
BJGP Open|February 20, 2020
Understanding the patient voice in gout: a quantitative study conducted in EuropeMarc De Meulemeester, Elsa Mateus, Hilda Wieberneit-Tolman, et al.
Annals of the Rheumatic Diseases|November 14, 2022
Clinical image: synovitis of the metacarpophalangeal jointsLinda van der Weele, Tom Niessink, Mario Maas, et al.
Annals of the Rheumatic Diseases|February 5, 2015
Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1RaTania O Crișan, Maartje C P Cleophas, Marije Oosting, et al.
Pageof 9